| Q38064970 | Antipsychotic discontinuation syndromes: a narrative review of the evidence and its integration into Australian mental health nursing textbooks |
| Q45140699 | Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. |
| Q50540496 | Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials. |
| Q90729533 | Changing prescribing patterns in an Irish community mental health service |
| Q47946228 | Childhood predictors of antipsychotic use among young people in Finland |
| Q39927947 | Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan |
| Q94337656 | Haloperidol (route of administration) for people with schizophrenia |
| Q24198264 | Haloperidol versus first generation antipsychotics for schizophrenia |
| Q24186601 | Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders |
| Q24194891 | Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia |
| Q24235300 | Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia |
| Q48362704 | Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer |
| Q37609382 | Impact of antipsychotic medication on the cost of schizophrenia |
| Q48831169 | Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program |
| Q51809456 | Initial prescription of antipsychotics and antidepressants in general practice and specialist care in Norway. |
| Q49061348 | Initiation of antipsychotic treatment by general practitioners. A case–control study |
| Q38437417 | National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom |
| Q38842111 | Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents |
| Q28552890 | Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012 |
| Q34799674 | Prescribing of antipsychotics in UK primary care: a cohort study. |
| Q38408656 | Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs. |
| Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
| Q88801271 | Prevalence of use of antipsychotic drugs in the elderly in Catalonia |
| Q24813593 | Primary care use of antipsychotic drugs: an audit and intervention study |
| Q28547129 | Psychotropic Drug Use in São Paulo, Brazil--An Epidemiological Survey |
| Q51925477 | Psychotropic drug epidemiology: the road travelled, the road ahead. |
| Q28303010 | Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis |
| Q37439130 | Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin |
| Q34083409 | The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study |
| Q51664413 | Treatment of major depressive disorder in the Finnish general population. |
| Q43550125 | [Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area]. |